PARP Inhibitor Maintenance Therapy after Initial Chemotherapy for Advanced Ovary, Fallopian Tube and Primary Peritoneal Cancers
Listen to Gynecologic Oncology
English - May 23, 2020 16:00 - 26 minutesScience Health & Fitness medicine health care science and technology health national health service medical disease cancer politics diabetes Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Special Topics: Present and Future Impact of COVID-19 on the Practice and Delivery on Gynecologic Oncology Care
Next Episode: August 2020: 2020 Virtual Annual SGO Meeting Report
Hosted by: Dr. Deborah K. Armstrong
Featuring: Dr. Eskander, Dr. O’Cearbhaill, Dr. Pothuri
Continuing education (CE)—0.5 credits—is available through SGO ConnectEd
Link: https://sgo.peachnewmedia.com/store/seminar/seminar.php?seminar=156603
CE description: The Society of Gynecology Oncology designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation on each activity.